Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial - Concepedia

Concepedia

Publication | Open Access

Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial

DOI Full Paper Access

21

Citations

10

References

2022

Year

Katherine E. Eddy, Joshua P. Vogel, Nick Scott, Dagnachew Fetene, Tom Tidhar, Olufemi T. Oladapo, Gilda Piaggio, My Huong Nguyen, Fernando Althabe, Rajiv Bahl,

The Lancet Global Health

Family MedicineWho Action-i TrialNeonatologyCost-effectiveness AnalysisHealth EconomicsPreterm LaborPediatricsMaternal HealthOutcomes ResearchPregnancyPreterm BirthPrenatal CareMaternal-fetal MedicineAntenatal DexamethasonePublic HealthMedicine

References

	Year	Citations

Page 1

Page 1